Iovance Biotherapeutics, Inc. (IOVA) vs PTC Therapeutics, Inc. (PTCT)
Iovance Biotherapeutics, Inc. and PTC Therapeutics, Inc. are both Biotechnology companies. Iovance Biotherapeutics, Inc. and PTC Therapeutics, Inc. are of similar size ($5.2B and $4.9B). Iovance Biotherapeutics, Inc. grew revenue faster over the last twelve months: 34.6% against −42.8%. PTC Therapeutics, Inc. has the higher net margin (−3.80% vs −89.1%) and the higher return on invested capital (15.2% vs −43.0%). Across the 16 metrics below, PTC Therapeutics, Inc. leads on 14 and Iovance Biotherapeutics, Inc. on 2.
Valuation
Profitability
| Metric | IOVA | PTCT | Biotechnology median |
|---|---|---|---|
| Gross margin | 48.40% | 92.99% | 65.16% |
| Operating margin | (92.72%) | 12.45% | 0.00% |
| Net margin | (89.09%) | (3.80%) | 0.00% |
| Free cash flow margin | (91.21%) | (29.76%) | 0.00% |
| Return on equity | (40.36%) | 20.64% | (57.72%) |
| Return on assets | (31.76%) | (1.30%) | (49.22%) |
| Return on invested capital | (42.96%) | 15.16% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack